Not all individuals with CLL need therapy. Irrespective of all latest innovations, the iwCLL nevertheless endorses watchful observation for sufferers with asymptomatic ailment.86 This advice relies on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 The two trials concluded that https://erwini319emu6.blogaritma.com/profile